ZeOmega

Jiva combines predictive analytics and agent-assisted utilization management with a substantial conventional enterprise platform. Smart UM includes learned extraction, approval-likelihood prediction, policy interpretation, and assisted review. Those functions materially change how staff process information and prioritize work. At the same time, care plans, member engagement, benefits administration, reporting, clinical content, and configurable rules retain value independently.

HealthUnity also supplies data aggregation and normalization for the broader platform. AI is therefore an important part of selected modules rather than the sole basis of the entire product. Customers can deploy individual Smart UM components alongside existing operational systems.

The AI policy explicitly prohibits using AI to deny care. Authorization workflows can execute configurable logic and route exceptions to the appropriate team with supporting information. Medical policy conversion is clinician guided and validated, while review assistance highlights evidence and suggests responses for a human reviewer. These are meaningful limits and review points, rather than an unrestricted automated denial workflow.

However, numeric escalation thresholds, conditions that stop a prediction or generated rule, and procedures for overriding and recovering from an incorrect result remain unspecified. Customers retain a substantial role in configuring rules and applying clinical judgment to exceptions.

The suite describes several technical roles: extracting fax data, predicting likelihood of approval, converting medical policies into decision trees, and assisting clinical reasoning with highlighted evidence. Configurable rules operate alongside learned models. The AI approach expressly includes third-party models and distinguishes ZeOmega from a foundation model developer.

However, those suppliers, model families, deployed versions, training sources, and model update controls are unspecified. The product descriptions explain what the modules do more clearly than how each model is built or selected. Fairness and drift monitoring are named capabilities, but their underlying evaluation methods and thresholds are not detailed.

Microsoft Azure and a private data center are identified infrastructure components, while the AI approach explicitly relies on third-party models. The actual model suppliers and the route by which customer information reaches inference services remain unnamed. Provider-specific retention, training permissions, and downstream contractual obligations are also unclear. A cloud provider identity does not establish the model used within that environment, leaving a partial view of the processing chain.

Kern Health Systems is a named Jiva customer using shared information and personalized care plans to coordinate physical and behavioral health needs. The accessible case describes integration, care management, and compliance workflows, but gives no dated quantitative evaluation, comparator, or measurement method. The detailed case is behind a download form.

Other established platform experiences demonstrate adoption and implementation history rather than effectiveness of the newer AI agents. The current Smart UM descriptions explain intended functions, including extraction and assisted review, without a reproducible outcome study. Evidence for the mature care-management platform therefore remains separate from validation of each current learned module.

The AI approach emphasizes privacy, explainability, and human review. Smart Auth Optimizer includes fairness and drift monitoring, while Medical Guidelines Assist highlights supporting evidence for clinical reviewers. Smart Fax Automator can learn from edits, which makes the handling of corrected customer material particularly relevant. Patient-data retention, permissions for model training or reuse, and deidentification rules remain unspecified for the enterprise service.

Detailed hallucination acceptance thresholds and a model safety incident process are also unclear. Website retention language does not establish those commitments for client health records, and general security controls answer a different question from safe interpretation of a medical policy.

HIPAA alignment and healthcare application assurance are part of the stated platform posture. The privacy notice, however, primarily covers public website information. Its client-information section explains that customer organizations determine the purposes of processing and directs individuals to those customers for service data terms. A readable enterprise BAA and its applicable product scope remain unavailable.

This leaves the permitted PHI uses and downstream business associate obligations unclear from the accessible contractual material. Security and interoperability accreditations provide related assurance, but do not by themselves establish the agreement governing a customer's records in each AI module.

SOC 2 assurance accompanies HITRUST certification, with the current DirectTrust registry showing HITRUST coverage through April 2028. The platform also has healthcare application and interoperability assurance that address additional operational requirements. These are recognized external assurance claims rather than only a list of internal controls.

A current full report with detailed service scope, examination period, control findings, and exceptions remains unavailable for direct inspection. The registry supports the current certification status, while the underlying audit would be needed to determine exactly which infrastructure and newer AI processing components fall within its assessed environment.

Jiva and Smart UM support population management, benefits administration, prior authorization, and medical necessity review. Their stated role is to organize information and assist operational and clinical reviewers within payer and provider workflows. Health application, interoperability, and AI governance accreditations concern different forms of assurance from FDA medical device authorization. No product-specific FDA clearance is identified for these AI functions.

The explicit prohibition on AI denial of care also describes an operating boundary rather than a regulatory clearance. Current positioning therefore remains an enterprise workflow and review-assistance product, without a claimed independently authorized diagnostic or treatment indication.

DirectTrust recognized ZeOmega's Foundational AI accreditation in June 2026. That program aligns with the Govern and Map components of the NIST AI Risk Management Framework, establishing organizational policies, procedures, and risk mapping. It is distinct from the Comprehensive level, which adds Measure and Manage for operational systems. Smart Auth Optimizer also describes fairness, bias, and drift monitoring as product functions.

These facts support a named governance process, but do not establish comparative subgroup results or comprehensive production-model evaluation. The accreditation's organizational scope remains important when interpreting assurance for a particular authorization or clinical review model.

Explainable recommendations, evidence highlighting, suggested responses, and staff review provide ways to challenge a result before it affects an authorization workflow. Configurable rules and exception routing also give customers operational control. An output accuracy guarantee, vendor indemnity, financial remedy, or contractual correction obligation remains unspecified for a mistaken recommendation or generated policy. Privacy access rights concerning client information are directed through the customer and do not establish a separate vendor process for appealing an AI result.

HealthUnity aggregates information from EHRs, claims, clearinghouses, laboratories, and pharmacy benefit systems into normalized organizational data. Smart Authorization Gateway adds FHIR-based eligibility, benefits, and authorization exchange, with routing among providers, payers, and delegated vendors. Kern Health Systems provides a named implementation involving information from disparate sources, and version-specific health information exchange testing adds technical context.

These facts establish meaningful integration depth. Current production writeback scope, supported versions, and exchange details for each named EHR remain unclear. Standards support and successful data consolidation therefore do not establish bidirectional clinical record access in every customer deployment.

The AI architecture combines a private data center with Microsoft Azure, and Jiva describes customer information as separate and private within its normalized data foundation. This identifies infrastructure choices and a customer separation intent. Committed service regions, detailed isolation controls, backup locations, and the geography of third-party model inference remain unspecified. The website policy's allowance for worldwide processing concerns its own scope and cannot establish the enterprise service's full residency terms.

Organizations purchase an enterprise platform with configurable modules, implementation support, and professional services. Smart UM components can operate independently or together, so the buying scope can range from a particular intake or review function to a larger utilization management deployment. This identifies a commercial structure but not a calculable price.

Subscription amounts, per-member or usage units, module charges, implementation fees, and minimum commitments remain unspecified before a sales discussion. The ability to select modules does not indicate which integration and service costs are included. A comparable initial budget therefore depends on the specific organizational agreement.

The platform addresses commercial health plans, Medicare Advantage, Medicaid managed care, health systems, and ACOs. Kern Health Systems supplies a concrete health plan example involving coordination of physical and behavioral care, with physicians, nurses, specialists, care managers, and members sharing information. The broader product spans care management, quality, risk adjustment, social needs, and authorization workflows rather than one clinical specialty.

That breadth is supported by established enterprise use, but measured validation is uneven for newer AI modules. A successful care-management deployment does not automatically establish the same performance for fax extraction, approval prediction, or generated policy logic in another organization.